Vivex Biomedical
Marietta, US · Founded 2012 · Delaware corporation
Find your way into Vivex Biomedical
179 people in our graph share verified history with the Vivex Biomedical team — schools, employers, funds. One of them is your warm intro.
Jon Phillipsunlockedknows Thomas J. Gibson · together at Streamline Health (overlapped)
knows the team · via Streamline Health
knows the team · via Citra Health Solutions
×6knows the team · via Greenway Medical Technologies
×3knows the team · via BDO Seidman
Founders & leadership
DH
Dr. H. Thomas TempleChief Medical Officer
BS
Barry SalzmanExecutive Chairman of Board of Directors
TJ
Thomas J. GibsonChief Financial Officer2014–2016Thomas J. Gibson is Chief Financial Officer at Vivex Biomedical. He has over 20 years of professional experience, including 15 years in public accounting and five years as a senior manager at a Big Four firm, with work across technology and healthcare sectors; he holds a CPA credential and has experience in M&A, SEC reporting, and operational process design.
HM
Holly MasonVice President of Marketing
TS
Tracy S. AndersonPresident and Chief Executive Officer
Board
RE
Richard E. PerlmanBoard director
JK
James K. PriceBoard director
JA
Jeffrey A. SmithBoard director
JM
J. Miguel Fernandez de CastroBoard director
TT
Timothy TaylorChairman of Board of Directors
JA
John A. McCallumBoard director
Reported raises · per SEC filings
Form D private placements$12.9M disclosed across 2 rounds · 2015–2017
▶$6.3MraisedMay 2017 · 38 investors · BiotechnologyRule 506(b)
▶$6.3MraisedMay 2017 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy Ganey, Ph.D.Executive Officer
- Holly MasonExecutive Officer
- John A. McCallumDirector
- Barry SalzmanDirector
- Dr. H Thomas TempleExecutive Officer
- James K. PriceDirector
- Tracy S. AndersonExecutive Officer, Director
- J. Miguel Fernandez de CastroDirector
- Timothy TaylorDirector
- U. Bertram Ellis, Jr.Director
- Stuart J KomenskiExecutive Officer
- Richard E. PerlmanDirector
- Offering amount
- $7M
- Amount sold
- $6.3M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6.6MraisedJan 2016 · 42 investors · BiotechnologyRule 506(b)
▶$6.6MraisedJan 2016 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. H. Thomas TempleExecutive Officer
- Richard E. PerlmanDirector
- James K. PriceDirector
- Barry SalzmanDirector
- Jeffrey A. SmithDirector
- J. Miguel Fernandez de CastroDirector
- Timothy TaylorDirector
- Ricardo J. NunezExecutive Officer
- John A. McCallumDirector
- Thomas J. GibsonExecutive Officer
- Holly MasonExecutive Officer
- Tracy S. AndersonExecutive Officer, Director
- U. Bertram Ellis, Jr.Director
- Timothy Ganey, Ph.D.Executive Officer
- Offering amount
- $10M
- Amount sold
- $6.6M
- Minimum investment
- $379
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Vivex Biomedical raised?
- Vivex Biomedical has disclosed $12.9M raised across 2 rounds.
- Where is Vivex Biomedical headquartered?
- Vivex Biomedical is headquartered in Marietta, US.


